Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy
Work
Year: 2022
Type: review
Abstract: Increasing evidence supports targeting the adenosine pathway in immuno-oncology with several clinical programs directed at adenosine A2 receptor (A2AR, A2BR), CD73 and CD39 in development. Through a c... more
Institutions University of Pittsburgh, Johns Hopkins University, Bloomberg (United States), Cancer Research Center, Sidney Kimmel Comprehensive Cancer Center +4 more
Cites: 90
Cited by: 78
Related to: 10
FWCI: 4.68
Citation percentile (by year/subfield): 98.98
Subfield: Physiology
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,600
Funder U.S. Department of Defense
Grant ID W81XWH-17-1-0265